Raiffeisen Bank International Ag Sarepta Therapeutics, Inc. Transaction History
Raiffeisen Bank International Ag
- $6.6 Trillion
- Q4 2024
A detailed history of Raiffeisen Bank International Ag transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 1,465 shares of SRPT stock, worth $156,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,465Holding current value
$156,930% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$973 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$932 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$464 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$436 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.38B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...